VIVIAN HASBROOK: Open Payments
NPI 1225101215 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,328 in 66 payments from 12 companies in 2025. Trend: 2023 $2,093 · 2024 $2,129 · 2025 $2,328
Food & beverage: $2,328
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $659 |
| ABBVIE INC. | 13 | $304 |
| Janssen Pharmaceuticals, Inc | 10 | $269 |
| Otsuka America Pharmaceutical, Inc. | 8 | $242 |
| E.R. Squibb & Sons, L.L.C. | 9 | $228 |
| Alkermes, Inc. | 5 | $190 |
| Lundbeck LLC | 7 | $161 |
| Neurocrine BioSciences, Inc. | 1 | $113 |
| Vanda Pharmaceuticals Inc. | 1 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: UZEDY, VRAYLAR, INVEGA SUSTENNA, COBENFY, REXULTI, ABILIFY ASIMTUFII, INGREZZA, FANAPT.
Industry payments across OK — which companies pay providers there.
